PNC Financial Services Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.4M Buy
46,351
+612
+1% +$343K 0.01% 401
2026
Q1
$25.7M Buy
45,739
+2,355
+5% +$1.51M 0.01% 381
2025
Q4
$29.4M Buy
43,384
+687
+2% +$468K 0.02% 358
2025
Q3
$27.3M Sell
42,697
-224
-0.5% -$136K 0.02% 369
2025
Q2
$23M Buy
42,921
+537
+1% +$257K 0.01% 378
2025
Q1
$17.8M Buy
42,384
+372
+0.9% +$162K 0.01% 413
2024
Q4
$17.4M Buy
42,012
+1,712
+4% +$751K 0.01% 409
2024
Q3
$20.4M Buy
40,300
+184
+0.5% +$89.4K 0.01% 392
2024
Q2
$19.5M Buy
40,116
+77
+0.2% +$38.7K 0.01% 391
2024
Q1
$21.6M Buy
40,039
+51
+0.1% +$27.9K 0.02% 381
2023
Q4
$22.2M Buy
39,988
+721
+2% +$338K 0.02% 371
2023
Q3
$17.2M Buy
39,267
+575
+1% +$287K 0.01% 390
2023
Q2
$19.4M Sell
38,692
-24,959
-39% -$12M 0.02% 383
2023
Q1
$31.8M Buy
63,651
+18
+0% +$8.61K 0.03% 302
2022
Q4
$26M Sell
63,633
-895
-1% -$347K 0.02% 332
2022
Q3
$21M Buy
64,528
+4,190
+7% +$1.54M 0.02% 354
2022
Q2
$21.2M Buy
60,338
+416
+0.7% +$170K 0.02% 360
2022
Q1
$32.8M Sell
59,922
-3,928
-6% -$2.07M 0.03% 325
2021
Q4
$42M Sell
63,850
-17,247
-21% -$10.8M 0.03% 302
2021
Q3
$50.4M Buy
81,097
+157
+0.2% +$105K 0.05% 264
2021
Q2
$51.1M Buy
80,940
+10,448
+15% +$5.77M 0.05% 258
2021
Q1
$34.5M Buy
70,492
+7,900
+13% +$3.96M 0.03% 310
2020
Q4
$31.3M Sell
62,592
-704
-1% -$315K 0.03% 318
2020
Q3
$24.9M Buy
63,296
+24,592
+64% +$9.09M 0.03% 327
2020
Q2
$12.8M Buy
38,704
+998
+3% +$289K 0.02% 402
2020
Q1
$9.13M Sell
37,706
-74
-0.2% -$19.3K 0.01% 429
2019
Q4
$9.86M Sell
37,780
-3,471
-8% -$915K 0.01% 473
2019
Q3
$11.2M Sell
41,251
-2,644
-6% -$736K 0.01% 461
2019
Q2
$12.1M Buy
43,895
+6,877
+19% +$1.69M 0.01% 474
2019
Q1
$8.28M Sell
37,018
-2,036
-5% -$420K 0.01% 565
2018
Q4
$7.26M Buy
39,054
+3,457
+10% +$709K 0.01% 566
2018
Q3
$8.89M Buy
35,597
+671
+2% +$163K 0.01% 576
2018
Q2
$7.61M Sell
34,926
-815
-2% -$168K 0.01% 621
2018
Q1
$6.84M Sell
35,741
-7
-0% -$1.29K 0.01% 628
2017
Q4
$5.59M Sell
35,748
-580
-2% -$91.3K 0.01% 695
2017
Q3
$5.65M Buy
36,328
+209
+0.6% +$33K 0.01% 664
2017
Q2
$5.83M Sell
36,119
-741
-2% -$120K 0.01% 628
2017
Q1
$5.7M Buy
36,860
+351
+1% +$48.4K 0.01% 635
2016
Q4
$4.28M Sell
36,509
-1,088
-3% -$124K ﹤0.01% 714
2016
Q3
$4.24M Sell
37,597
-175
-0.5% -$18.4K ﹤0.01% 702
2016
Q2
$3.51M Sell
37,772
-151
-0.4% -$13K ﹤0.01% 740
2016
Q1
$2.97M Buy
37,923
+384
+1% +$27.7K ﹤0.01% 780
2015
Q4
$2.74M Buy
37,539
+2,109
+6% +$150K ﹤0.01% 791
2015
Q3
$2.63M Buy
35,430
+1,011
+3% +$72.4K ﹤0.01% 826
2015
Q2
$2.21M Buy
34,419
+6,653
+24% +$461K ﹤0.01% 938
2015
Q1
$2.14M Sell
27,766
-2,544
-8% -$198K ﹤0.01% 927
2014
Q4
$2.25M Buy
30,310
+422
+1% +$29.6K ﹤0.01% 874
2014
Q3
$1.76M Buy
29,888
+20,746
+227% +$1.31M ﹤0.01% 940
2014
Q2
$611K Sell
9,142
-200
-2% -$12.7K ﹤0.01% 1320
2014
Q1
$568K Buy
9,342
+174
+2% +$10.4K ﹤0.01% 1330
2013
Q4
$487K Sell
9,168
-14,800
-62% -$779K ﹤0.01% 1398
2013
Q3
$1.19M Sell
23,968
-3,492
-13% -$168K ﹤0.01% 951
2013
Q2
$1.23M Buy
+27,460
New +$1.2M ﹤0.01% 918

Other funds holding IDXX

PNC Financial Services Group's IDXX Position: Q2 2026 in Review

PNC Financial Services Group increased its Idexx Laboratories (IDXX) stake by 1.3% in Q2 2026, buying an estimated $343K and bringing the position to 46,351 shares worth $24.4M. The position accounts for 0.01% of the portfolio, ranked #401.

PNC Financial Services Group first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $51.1M in Q2 2021. 743 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • PNC Financial Services Group held 46,351 shares of Idexx Laboratories worth $24.4M as of Q2 2026.
  • PNC Financial Services Group bought 612 Idexx Laboratories shares in Q2 2026, an estimated $343K.
  • Idexx Laboratories made up 0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #401 holding.
  • PNC Financial Services Group first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • PNC Financial Services Group's Idexx Laboratories position peaked at $51.1M in Q2 2021.
  • 743 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.